FDA Clearance Tracker · K262392
APRO 35 Swift Catheter
Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 12, 2026
Substantially Equivalent
Time to decision
29 days
Received Jul 14, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K262392
- Device name
- APRO 35 Swift Catheter
- Applicant
- Alembic, LLC
- Applicant location
- Mountain View, CA
- Received
- Jul 14, 2026
- Decided
- Aug 12, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Catheter, Percutaneous (DQY)
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DQY. The earliest in FDA's data is K790083, decided Jan 25, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K262392
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Alembic, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- APRO 88 Catheter510(k)
K261938 · Decided Oct 6, 2026 · 118 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K262391 · Decided Aug 12, 2026 · 29 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
- APRO 45 Catheter510(k)
K251014 · Decided May 1, 2025 · 29 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.